美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

艾格里房產

75.40

+0.77001.03%

成交量：14.82萬

成交額：1,113.41萬

市值：82.79億

市盈率：42.63

高：75.48

開：74.72

低：74.58

收：74.63

資料載入中...

總覽公司新聞公告

巴克萊：維持Agree Realty(ADC.US)評級，由持股觀望調整至持股觀望評級, 目標價由75.00美元調整至77.00美元。

港股異動 | 石藥集團(01093)漲超4% 旗下ADC新藥再獲FDA快速通道資格 JMT106獲中國臨牀試驗批准

再鼎醫藥：DLL3 ADC獲FDA快速通道資格認定，用於治療ES-SCLC

生物药大时代

先聲藥業盤中漲超7% FGFR2b靶點ADC完成I期臨牀首例患者給藥

三生製藥12億美元賣掉一款新藥，創下國產藥交易價新高

港股異動 | 再鼎醫藥(09688)漲超10% 一季度總收入同比增長兩成機構建議關注其DLL3 ADC數據更新

一週IPO觀察：寧王、恆瑞申購踴躍，綠茶破發且綠鞋用盡，手回集團過訊

财经自媒体

軒竹生物軒悅寧®（吡洛西利片）獲批雙適應症，為乳腺癌治療帶來革新突破

一天兩條好消息！來自艾伯維

生物制品圈

太平洋醫藥日報：艾伯維ADC藥物EMRELIS獲FDA批准

太平洋证券股份...

艾伯維(ABBV.US)宣佈FDA已加速批准旗下抗體偶聯藥物(ADC)Emrelis上市

3.35億美元首付款！艾伯維盯上小核酸藥物開發

ADC Therapeutics(ADCT.US)：2025年Q1財報實現營收2303萬美元，前值為1805.3萬美元，預期值為1815萬美元；每股收益為-0.22美元，前值為-0.38美元，預期值為-0.38美元。

一季報“開門紅”！50家藥械企業淨利翻倍

默沙東/科倫博泰 TROP2 ADC 又雙叒叕啓動 III 期臨牀試驗

Insight数据库

健訊Daily | 鄭州通報“健康證”辦理有關問題；中國醫藥擬3.02億元收購金穗科技100%股權

21世纪经济报道

輝瑞(PFE)PD-L1 ADC在國內啓動Ⅰ期臨牀

輝瑞(PFE.US)PD-L1 ADC在國內首次啓動臨牀

從PD-1跟隨到多款ADC領先，樂普生物-B（02157）迎價值重估？

林園持續增配！這個行業利好消息不斷

证券市场周刊

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ADC/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ADC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADC\",,,,,undefined,":{"symbol":"ADC","market":"US","secType":"STK","nameCN":"艾格里房產","latestPrice":75.4,"timestamp":1750261023364,"preClose":74.63,"halted":0,"volume":148156,"delay":0,"floatShares":107714195,"shares":109806548,"eps":1.768583,"marketStatus":"交易中","change":0.77,"latestTime":"06-18 11:37:22 EDT","open":74.72,"high":75.48,"low":74.58,"amount":11134055.851464,"amplitude":0.012059,"askPrice":75.42,"askSize":165,"bidPrice":75.38,"bidSize":5,"shortable":3,"etf":0,"ttmEps":1.768583,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1750276800000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":766296000000,"exchange":"NYSE","adjPreClose":74.63,"dividendRate":0.040027,"preHourTrading":{"tag":"盘前","latestPrice":75.08,"preClose":74.63,"latestTime":"09:12 EDT","volume":21,"amount":1564.0199400000001,"timestamp":1750252372265},"postHourTrading":{"tag":"盘后","latestPrice":74.65,"preClose":74.65,"latestTime":"18:03 EDT","volume":19202,"amount":1433447.6,"timestamp":1750197823741},"volumeRatio":0.516783,"impliedVol":0.2439,"impliedVolPercentile":0.764},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADC\",,,,,undefined,":{"symbol":"ADC","floatShares":107714195,"roa":"2.30%","roe":"3.55%","lyrEps":1.793039,"volumeRatio":0.516783,"shares":109806548,"dividePrice":3.018,"high":75.48,"amplitude":0.012059,"preClose":74.63,"low":74.58,"week52Low":60.42,"pbRate":"1.51","psRate":"13.00","week52High":79.65,"institutionHeld":0.9993,"latestPrice":75.4,"committee":-0.941176,"eps":1.768583,"divideRate":0.040027,"volume":148156,"delay":0,"ttmEps":1.768583,"open":74.72,"prevYearClose":70.45,"prevWeekClose":74.55,"prevMonthClose":75.3,"prevQuarterClose":77.19,"fiveDayClose":74.54,"twentyDayClose":75.82,"sixtyDayClose":75.71},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ADC\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2537311329","title":"巴克萊：維持Agree Realty(ADC.US)評級，由持股觀望調整至持股觀望評級, 目標價由75.00美元調整至77.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2537311329","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537311329?lang=zh_tw&edition=fundamental","pubTime":"2025-05-21 22:22","pubTimestamp":1747837332,"startTime":"0","endTime":"0","summary":"巴克莱：维持Agree Realty(ADC.US)评级，由持股观望调整至持股观望评级, 目标价由75.00美元调整至77.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/21222250576366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ADC"],"gpt_icon":0},{"id":"2537467452","title":"港股異動 | 石藥集團(01093)漲超4% 旗下ADC新藥再獲FDA快速通道資格 JMT106獲中國臨牀試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2537467452","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537467452?lang=zh_tw&edition=fundamental","pubTime":"2025-05-21 11:56","pubTimestamp":1747799781,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，石药集团再涨超4%，截至发稿，涨3.81%，报6.54港元，成交额8.59亿港元。此外，由石药集团开发的双特异性融合蛋白药物JMT106已获中华人民共和国国家药品监督管理局批准，可以在中国开展临床试验。该产品亦已于2024年1月获得美国食品药品监督管理局批准在美国开展临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1295707.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1226287529.USD","BK4231","IE0008369823.USD","LU1226287792.SGD","BK1521","LU1960683339.HKD","LU1993786604.SGD","IE00BZ08YT58.USD","03347","IE00BZ08YS42.EUR","SG9999004220.SGD","LU0140636845.USD","LU1226288253.USD","LU1152091168.USD","IE00BZ08YR35.GBP","BK1515","IE00B5MMRT66.SGD","LU1226287875.USD","IE00B543WZ88.USD","BK1576","LU0501845795.SGD","IE00B031HY20.USD","BK4080","LU1152091754.HKD","01093","BK1583","LU0067412154.USD","IE0008368742.USD","BK1141","LU0326950275.SGD","ADC","LU1807302812.USD","BK1191","LU1008478684.HKD","LU0072913022.USD","LU1951186391.HKD","LU1226288170.HKD","LU0880133367.SGD"],"gpt_icon":0},{"id":"2537530677","title":"再鼎醫藥：DLL3 ADC獲FDA快速通道資格認定，用於治療ES-SCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2537530677","media":"生物药大时代","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537530677?lang=zh_tw&edition=fundamental","pubTime":"2025-05-21 11:33","pubTimestamp":1747798415,"startTime":"0","endTime":"0","summary":"近日，再鼎医药宣布，FDA已授予具有同类首创潜力的Delta样配体3ADC ZL-1310快速通道资格认定，用于治疗广泛期小细胞肺癌。Rafael G. Amado博士再鼎医药总裁，全球研发负责人Rafael G. Amado博士表示，FDA授予ZL-1310快速通道资格，凸显了SCLC患者对扩大治疗选择的迫切需求，也标志着我们在加速推进这一新疗法进程中迈出关键一步。再鼎医药是一家以研发为基础、处于商业化阶段的创新型生物制药公司，总部位于中国和美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521125944a48640b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521125944a48640b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IE00BZ18W456.USD","ES","LU1880398471.USD","LU1880398554.USD","BK4585","LU2637428348.USD","BK4526","BK4081","IE00BMG7P694.USD","BK4588","IE00BMG7P587.USD","LU1883839398.USD","09688","IE00BZ18W340.USD","ZLAB","IE00BMQBXF63.USD","IE00B29SXK94.USD","IE00BMG7P819.SGD","BK4231","LU1803068623.USD","BK4080","ADC","IE00B29SXL02.USD","BK4531","BK4548","LU2449327464.USD","LU2488822045.USD","IE00BMG7P926.USD"],"gpt_icon":0},{"id":"2537115675","title":"先聲藥業盤中漲超7% FGFR2b靶點ADC完成I期臨牀首例患者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2537115675","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537115675?lang=zh_tw&edition=fundamental","pubTime":"2025-05-21 10:10","pubTimestamp":1747793400,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　先声药业（02096）盘中涨超7%，截至发稿，股价上涨5.91%，现报10.40港元，成交额1.02亿港元。\n　　5月20日，先声药业旗下抗肿瘤创新药公司先声再明宣布，其自主研发的FGFR2b（成纤维细胞生长因子受体2b ）靶点抗体药物偶联物（ADC）候选创新药SIM0686已启动针对晚期实体瘤的Ⅰ期临床研究，并于南京天印山医院完成首例患者给药。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-05-21/doc-inexhsqm3031771.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ADC","BK4080","BK4231","02096","BK1191","BK1583"],"gpt_icon":0},{"id":"2536713699","title":"三生製藥12億美元賣掉一款新藥，創下國產藥交易價新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2536713699","media":"界面","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536713699?lang=zh_tw&edition=fundamental","pubTime":"2025-05-20 16:36","pubTimestamp":1747730192,"startTime":"0","endTime":"0","summary":"同时，它拥有最高可达48亿美元的后续里程碑付款，总价突破60亿美元。5月20日，三生制药开盘一度涨超30%。而三生国健继5月19日涨停后，再度涨停。三生国健康是三生制药旗下公司，也是本次协议的签署方之一。若是从更长的时间跨度观测，从今年2月起，三生制药累计涨幅已超200%。近两年内，随着双抗产品授权交易频发，该领域内的在研新药受到广泛关注。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520163815a4851ea4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520163815a4851ea4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4534","LU0225284248.USD","LU0985481810.HKD","SGXZ57979304.SGD","SG9999003800.SGD","LU0122379950.USD","LU1894683348.USD","BMS","LU1883839398.USD","LU0225771236.USD","IE00BBT3K403.USD","BK4080","LU0289739699.SGD","LU0306807586.USD","LU1066053197.SGD","LU1894683264.USD","IE00B19Z3B42.SGD","LU0321505868.SGD","01530","LU0058720904.USD","ADC","LU1023059063.AUD","IE0002270589.USD","LU0306806265.USD","BK4007","BK4585","SG9999002232.USD","BK4588","IE000M9KFDE8.USD","IE00BLSP4452.SGD","BK4231","BK4599","LU0321505439.SGD","SG9999013999.USD","BK4550","BK4533","IE00B19Z3581.USD","LU0170899867.USD","LU0868494617.USD","SG9999002224.SGD","SG9999011175.SGD","IE00BLSP4239.USD","LU1057294990.SGD","SG9999001176.USD","LU1066051498.USD","BK4592","LU0456855351.SGD","LU0234572021.USD","MSD"],"gpt_icon":1},{"id":"2536720805","title":"港股異動 | 再鼎醫藥(09688)漲超10% 一季度總收入同比增長兩成  機構建議關注其DLL3 ADC數據更新","url":"https://stock-news.laohu8.com/highlight/detail?id=2536720805","media":"智通财经","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536720805?lang=zh_tw&edition=fundamental","pubTime":"2025-05-19 15:25","pubTimestamp":1747639531,"startTime":"0","endTime":"0","summary":"消息面上，再鼎医药近日发布，一季度实现总收入1.06亿美元，同比增加22.19%；研发开支6072.9万美元，同比增加11.13%。其中，2025年第一季度产品收入净额为1.057亿美元，2024年同期为8710万美元，同比增长 21%，按固定汇率计算同比增长23%。这一研究旨在评估公司具有同类首创和同类最佳潜力的DLL3 ADC，用于治疗ES-SCLC。浦银国际指出，多重催化剂下，建议重点关注DLL3 ADC在ASCO大会上的一期数据更新及潜在出海。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1294737.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4548","BK1588","BK4585","BK4139","BK4080","BK1161","BK4231","BK4531","ZLAB","BK4588","09688","ADC","BK4526","LU2488822045.USD","BK1574"],"gpt_icon":0},{"id":"2536960524","title":"一週IPO觀察：寧王、恆瑞申購踴躍，綠茶破發且綠鞋用盡，手回集團過訊","url":"https://stock-news.laohu8.com/highlight/detail?id=2536960524","media":"财经自媒体","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536960524?lang=zh_tw&edition=fundamental","pubTime":"2025-05-19 11:27","pubTimestamp":1747625220,"startTime":"0","endTime":"0","summary":"港股IPO观察截止2025年的第20周，港交所3家新股上市，1家招股，3家通过聆讯，8家递交招股书。首日大跌12%，招银国际为稳价人，绿鞋已基本用完。本次IPO每股发售价23.30港元，计划全球发售4662万股，无超额配股权。手回集团通过IPO聆讯5月15日，小雨伞保险的母公司深圳手回集团在港交所披露聆讯后的招股书，或很快在香港主板IPO上市。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-05-19/doc-inexakse3019512.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1198","02629","LU1504937902.USD","LU1251922891.USD","FMFC","LU1720050803.USD","LU0828237940.HKD","DLHZ","RNA","OMSE","BK4080","LU0096374516.USD","LU0345780281.USD","LU0405327494.USD","LAWR","BK4585","600276","RNBW","02565","BK0188","HSPO","HK0000320223.HKD","BK1544","EGG","LU0370786039.SGD","FTRK","ETOR","LU0886674414.USD","ADC","BK4023","HK0000306701.USD","LU2097828714.EUR","ARAI","BK0183","LU0572944931.SGD","MSGY","02899","LU1064130708.USD","BK4231","LHAI","02603","LU1969619763.USD","01276","LU2097828805.USD","03750","LU1328615791.USD","LU0345780521.USD"],"gpt_icon":1},{"id":"2535362778","title":"軒竹生物軒悅寧®（吡洛西利片）獲批雙適應症，為乳腺癌治療帶來革新突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2535362778","media":"美通社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535362778?lang=zh_tw&edition=fundamental","pubTime":"2025-05-16 12:01","pubTimestamp":1747368060,"startTime":"0","endTime":"0","summary":"吡洛西利片的上市，无疑为这一庞大的患者群体提供了全新且有效的治疗选择。吡洛西利片针对我国乳腺癌患者发病特点开展的临床试验，数据极具临床价值。吡洛西利片凭借其独特的双适应症及卓越疗效，有望在市场中占据重要份额。这一举措不仅体现了企业的社会责任，也将进一步推动吡洛西利片在临床治疗中的广泛应用，为更多乳腺癌患者带来健康福祉。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4689736_ZH89736_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK1191","00460","BK1593","ADC","BK4231","BK4080","HR","BK4203","BK1600","BK4225","BK1515"],"gpt_icon":0},{"id":"2535357325","title":"一天兩條好消息！來自艾伯維","url":"https://stock-news.laohu8.com/highlight/detail?id=2535357325","media":"生物制品圈","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535357325?lang=zh_tw&edition=fundamental","pubTime":"2025-05-16 10:42","pubTimestamp":1747363357,"startTime":"0","endTime":"0","summary":"肺癌一直是全球癌症相关死亡的首要原因，而EMRELIS的出现，无疑为那些预后不良且治疗选择有限的患者带来了新的希望。此次EMRELIS的获批和与ADARx的合作，正是艾伯维在这一使命上的重要体现。对于患者来说，这一天的两条好消息无疑带来了双重的喜悦和希望。艾伯维公司通过不懈的努力和创新，正在为全球患者创造更加美好的未来。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516162056a4809f0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516162056a4809f0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABBV","BK4533","LU2089283258.USD","ADC","LU0234570918.USD","LU0553294199.USD","SG9999015952.SGD","LU0965508806.USD","LU2023251221.USD","LU1934455863.HKD","SG9999015945.SGD","LU1074936037.SGD","LU2129689431.USD","BK4080","IE0002270589.USD","LU2112291526.USD","IE00B19Z3581.USD","IE00BGHQF631.EUR","LU0795875086.SGD","LU1244550577.SGD","BK4585","LU1162221912.USD","LU0211328371.USD","LU0029864427.USD","LU0256863811.USD","LU1430594728.SGD","LU1983299246.USD","LU0689472784.USD","LU0965509283.SGD","LU0234572021.USD","LU0985320562.USD","LU1057294990.SGD","LU2237443622.USD","LU2129689605.HKD","SG9999011175.SGD","LU0820561818.USD","LU0738911758.USD","LU1267930490.SGD","LU1732799900.SGD","LU0211327993.USD","LU0795875169.SGD","SG9999003800.SGD","ORR","LU0203347892.USD","LU2237443978.SGD","SG9999015978.USD","LU0949170772.SGD","LU0114720955.EUR","LU1023059063.AUD","LU1244550221.USD"],"gpt_icon":0},{"id":"2535318609","title":"太平洋醫藥日報：艾伯維ADC藥物EMRELIS獲FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2535318609","media":"太平洋证券股份...","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535318609?lang=zh_tw&edition=fundamental","pubTime":"2025-05-16 00:00","pubTimestamp":1747324800,"startTime":"0","endTime":"0","summary":"Emrelis 是一款靶向c-Met 的ADC，以微管蛋白抑制剂MMAE 作为毒性有效载荷，是首个获批用于治疗高c-Met 蛋白过度表达的经治晚期NSCLC 患者的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516210737975bd320&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516210737975bd320&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B19Z3581.USD","LU0943347566.SGD","SG9999011175.SGD","BK4231","LU1003077747.HKD","LU1839511570.USD","LU0661504455.SGD","IE00BJT1NW94.SGD","ABBV","IE00BVYPNV92.GBP","LU0122379950.USD","LU1244550577.SGD","LU1430594728.SGD","LU1585245621.USD","LU0795875169.SGD","LU0203347892.USD","LU0820561909.HKD","IE00B42XCP33.USD","LU0708994859.HKD","BK4559","LU0198837287.USD","LU1057294990.SGD","IE0002141913.USD","IE0004445239.USD","ADC","LU1732800096.USD","BK4585","LU0912757837.SGD","LU0795875086.SGD","IE00BFTCPJ56.SGD","SG9999001440.SGD","LU1934455277.USD","BK4080","LU2087621335.USD","BK4534","LU2089284900.SGD","LU2237443382.USD","LU0820561818.USD","LU1551013425.SGD","LU1093756168.USD","LU2237443978.SGD","LU0029864427.USD","LU0234572021.USD","LU0211327993.USD","LU0965508806.USD","LU1934455863.HKD","LU0949170772.SGD","LU1037948541.HKD","LU2347655156.SGD","LU0965509283.SGD"],"gpt_icon":0},{"id":"2535825897","title":"艾伯維(ABBV.US)宣佈FDA已加速批准旗下抗體偶聯藥物(ADC)Emrelis上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2535825897","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535825897?lang=zh_tw&edition=fundamental","pubTime":"2025-05-15 21:18","pubTimestamp":1747315100,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，今日，艾伯维宣布，美国FDA已加速批准旗下抗体偶联药物Emrelis上市，用于治疗具有高c-Met蛋白过度表达的局部晚期或转移性非鳞状非小细胞肺癌成年患者，这些患者此前已接受过系统性治疗。高c-Met蛋白过度表达被定义为：经FDA批准的检测方法确定，≥50%的肿瘤细胞显示强阳性(3+)染色。Teliso-V是一款靶向c-Met的ADC，以微管蛋白抑制剂MMAE作为毒性有效载荷。该疗法在2022年1月获FDA突破性疗法认定，治疗非小细胞肺癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1293803.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BFTCPJ56.SGD","LU1244550577.SGD","LU1718418525.SGD","LU1929549753.HKD","LU1291159041.SGD","LU2129689514.USD","LU2129689605.HKD","LU2468319806.SGD","LU0820561909.HKD","LU1989772840.SGD","LU1839511570.USD","IE00B19Z3B42.SGD","LU0949170772.SGD","LU0965509010.AUD","IE00B4R5TH58.HKD","BK4585","LU0795875086.SGD","LU1585245621.USD","SG9999015945.SGD","LU0128525929.USD","LU0882574055.USD","LU1496350171.SGD","LU0256863811.USD","LU1989771016.USD","LU1267930490.SGD","LU0738911758.USD","LU0795875169.SGD","LU0310799852.SGD","LU1023059063.AUD","LU1934455863.HKD","ABBV","LU1934455194.USD","LU0417517546.SGD","LU0689472784.USD","IE0002141913.USD","IE00B42XCP33.USD","LU0310800379.SGD","LU0170899867.USD","BK4559","LU1061106388.HKD","LU1162221912.USD","LU0234572021.USD","LU0661504455.SGD","LU2237443978.SGD","LU1037948541.HKD","ADC","LU0203347892.USD","LU0456855351.SGD","LU2133065610.SGD","LU0203345920.USD"],"gpt_icon":0},{"id":"2535328728","title":"3.35億美元首付款！艾伯維盯上小核酸藥物開發","url":"https://stock-news.laohu8.com/highlight/detail?id=2535328728","media":"时代财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535328728?lang=zh_tw&edition=fundamental","pubTime":"2025-05-15 09:48","pubTimestamp":1747273738,"startTime":"0","endTime":"0","summary":"本文来源：时代财经5月15日，时代财经获悉，艾伯维和ADARx Pharmaceuticals宣布达成合作和许可选择协议，以开发涵盖神经科学、免疫学和肿瘤学等多个疾病领域的小干扰RNA  疗法。艾伯维将酌情贡献其在抗体工程、抗体药物偶联物和组织递送方法方面的专业知识，以增强ADARx的发现能力。根据协议条款，ADARx将获得3.35亿美元的预付款，并有资格获得数十亿美元的额外或有付款，包括期权相关费用和里程碑付款以及分级特许权使用费。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515094919975a1874&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515094919975a1874&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999003800.SGD","IE00B4R5TH58.HKD","IE00B3PB1722.GBP","IE00BVYPNV92.GBP","ABBV","LU0456855351.SGD","LU0689472784.USD","LU2237443382.USD","LU1839511570.USD","LU1989771016.USD","LU0114720955.EUR","IE0002270589.USD","LU1244550494.USD","LU2023251221.USD","BK4534","LU0912757837.SGD","LU1037948541.HKD","LU1037948897.HKD","LU0985320562.USD","LU1291159041.SGD","LU0820561818.USD","LU0949170772.SGD","LU0738911758.USD","LU0965509283.SGD","LU1267930490.SGD","LU1003077747.HKD","LU1934455194.USD","IE00BGHQF631.EUR","IE0009355771.USD","LU0234572021.USD","LU1430594728.SGD","LU1496350171.SGD","LU1732799900.SGD","LU2089984988.USD","LU0128525929.USD","BK4550","LU0158827948.USD","LU0211328371.USD","LU2112291526.USD","IE0002141913.USD","ADC","LU0256863811.USD","SG9999015986.USD","LU2237443465.HKD","IE00BJJMRZ35.SGD","LU1244550221.USD","BK4581","IE0004445239.USD","LU0310799852.SGD","LU1074936037.SGD"],"gpt_icon":0},{"id":"2535947026","title":"ADC Therapeutics(ADCT.US)：2025年Q1財報實現營收2303萬美元，前值為1805.3萬美元，預期值為1815萬美元；每股收益為-0.22美元，前值為-0.38美元，預期值為-0.38美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535947026","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535947026?lang=zh_tw&edition=fundamental","pubTime":"2025-05-14 20:12","pubTimestamp":1747224725,"startTime":"0","endTime":"0","summary":"ADC Therapeutics(ADCT.US)：2025年Q1财报实现营收2303万美元，前值为1805.3万美元，预期值为1815万美元；每股收益为-0.22美元，前值为-0.38美元，预期值为-0.38美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/14201250390988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","ADCT","ADC"],"gpt_icon":0},{"id":"2535043622","title":"一季報“開門紅”！50家藥械企業淨利翻倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2535043622","media":"市场资讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535043622?lang=zh_tw&edition=fundamental","pubTime":"2025-05-14 17:25","pubTimestamp":1747214700,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！　　A股生物医药行业一季度成绩单已“出炉”，不少上市公司今年实现“开门红”。　　盈利情况上，有381家药械企业实现盈利，另有50家药械企业实现净利翻倍。　　截至目前，A股494家生物医药行业上市公司2025年第一季度业绩报告均已发布。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hyyj/2025-05-14/doc-inewprwu5944359.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06978","399300","ADC","BK1574","BK1583","BK1161","BK4231","09997","09996","BK1100","159982","BK1222","BK4080","CXO"],"gpt_icon":0},{"id":"2535090653","title":"默沙東/科倫博泰 TROP2 ADC 又雙叒叕啓動 III 期臨牀試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2535090653","media":"Insight数据库","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535090653?lang=zh_tw&edition=fundamental","pubTime":"2025-05-14 15:02","pubTimestamp":1747206169,"startTime":"0","endTime":"0","summary":"5 月 13 日，ClinicalTrials 网站显示，默沙东登记了一项比较 Sac-TMT联合帕博利珠单抗和卡铂/紫杉醇对比化疗联合帕博利珠单抗新辅助治疗高危、早期三阴性乳腺癌或激素受体低阳性/人表皮生长因子受体 2 阴性乳腺癌的 III 期临床研究。Insight 数据库显示，这是默沙东针对该药启动的第 14 项全球多中心临床试验，此前还有 13 项临床试验，涉及卵巢癌、宫颈癌、胃癌、非小细胞肺癌、子宫内膜癌等。该药首次于 2024 年 11 月获 NMPA 批准上市，用于三阴性乳腺癌的二线治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514152826a6de97f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514152826a6de97f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4516","LU0965509101.SGD","LU0208291251.USD","LU0122379950.USD","LU1116320737.USD","SG9999001176.USD","SG9999001440.SGD","III","LU1093756325.SGD","LU1093756168.USD","SG9999014559.SGD","IE0002141913.USD","LU0006306889.USD","LU1023059063.AUD","LU1941712264.USD","BK4559","LU1037948897.HKD","BK4534","LU1037948541.HKD","LU0265550359.USD","LU2324357040.USD","SG9999015358.SGD","SG9999015341.SGD","LU2089984988.USD","IE00BN8TJ469.HKD","IE0009355771.USD","SG9999013999.USD","SG9999002232.USD","LU0965509010.AUD","LU1989772840.SGD","MRK","LU1989771016.USD","LU1989772923.USD","LU0211331839.USD","LU0320765489.SGD","LU0965508806.USD","LU0203345920.USD","SGXZ57979304.SGD","LU1929549753.HKD","LU1162221912.USD","LU1430594728.SGD","SG9999014575.USD","ADC","LU0289739699.SGD","IE00BJT1NW94.SGD","BK4533","LU0320765646.SGD","LU1571399168.USD","LU2468319806.SGD","LU1917777945.USD"],"gpt_icon":1},{"id":"2535423032","title":"健訊Daily | 鄭州通報“健康證”辦理有關問題；中國醫藥擬3.02億元收購金穗科技100%股權","url":"https://stock-news.laohu8.com/highlight/detail?id=2535423032","media":"21世纪经济报道","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535423032?lang=zh_tw&edition=fundamental","pubTime":"2025-05-14 07:58","pubTimestamp":1747180699,"startTime":"0","endTime":"0","summary":"政策动向国家药监局：全过程深化药品监管改革全方位筑牢药品安全底线5月13日，第36届医药经济信息发布会在广州召开。国家药监局副局长徐景和表示，要全面贯彻落实党的二十届三中全会精神，落实《国务院办公厅关于全面深化药品医疗器械监管改革促进医药产业高质量发展的意见》，全过程深化药品监管改革、全方位筑牢药品安全底线、全链条支持产业高质量发展，为保护和促进公众健康作出更大贡献。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202505143403788212.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202505143403788212.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["PFS","BK4211","BK4231","HCC","BK4195","BK4006","BK4017","CDE","BK4097","ADC","OS","BK4080"],"gpt_icon":0},{"id":"2535271637","title":"輝瑞(PFE)PD-L1 ADC在國內啓動Ⅰ期臨牀","url":"https://stock-news.laohu8.com/highlight/detail?id=2535271637","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535271637?lang=zh_tw&edition=fundamental","pubTime":"2025-05-13 16:27","pubTimestamp":1747124827,"startTime":"0","endTime":"0","summary":"金吾财讯 | 5月12日，药物临床试验登记与信息公示平台显示，辉瑞(PFE)在国内启动了一项PF-08046054针对实体瘤患者的Ⅰ期临床。PF-08046054(SGN-PDL1V)是辉瑞收购Seagen获得的一款靶向PD-L1的ADC。这项Ⅰ期临床旨在评估PF-08046054作为单药治疗晚期实体恶性肿瘤受试者。Insight数据库显示，全球目前共有2款靶向PD-L1的ADC进入临床阶段。除了辉瑞的PF-08046054，另外一款为宜联生物/复宏汉霖的HLX43，目前正在开展Ⅱ期临床阶段。","market":"us","thumbnail":"https://static.szfiu.com/news/20250107/MDE2NGUxYWJlMGQ4OGQwMTU5ZTY5YzEzNTY0MzU1Mzgx.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/MDE2NGUxYWJlMGQ4OGQwMTU5ZTY5YzEzNTY0MzU1Mzgx.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"288443","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225284248.USD","PD","LU0985481810.HKD","BK4080","IE000M9KFDE8.USD","BK4581","LU0058720904.USD","BK4588","SG9999002232.USD","SG9999013999.USD","LU1066051498.USD","IE0002270589.USD","BK4550","IE00B19Z3581.USD","LU0122379950.USD","ADC","BK4534","BK4592","IE00BBT3K403.USD","IE00BLSP4452.SGD","LU1057294990.SGD","SG9999001176.SGD","BK4023","SG9999001176.USD","BK4599","LU1883839398.USD","BK4568","LU0306807586.USD","LU0868494617.USD","BK4007","LU0456855351.SGD","BK4231","LU0306806265.USD","LU0321505439.SGD","LU1169589451.USD","LU0234572021.USD","SG9999011175.SGD","BK4585","SG9999002224.SGD","LU0170899867.USD","LU0321505868.SGD","LU1894683348.USD","LU1894683264.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","PFE","SG9999003800.SGD","SGXZ57979304.SGD","LU0225771236.USD","LU1066053197.SGD"],"gpt_icon":0},{"id":"2535713135","title":"輝瑞(PFE.US)PD-L1 ADC在國內首次啓動臨牀","url":"https://stock-news.laohu8.com/highlight/detail?id=2535713135","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535713135?lang=zh_tw&edition=fundamental","pubTime":"2025-05-13 16:02","pubTimestamp":1747123376,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，5月12日，药物临床试验登记与信息公示平台显示，辉瑞在国内启动了一项PF-08046054针对实体瘤患者的Ⅰ期临床。研究的主要终点指标是安全性，次要终点指标是有效性。Insight数据库显示，全球目前共有2款靶向PD-L1的ADC进入临床阶段。除了辉瑞的PF-08046054，另外一款为宜联生物/复宏汉霖的HLX43，目前正在开展Ⅱ期临床阶段。此外，还有三款靶向PD-L1的双靶点ADC进入临床，分别来自信达、映恩、康宁杰瑞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1292471.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0234572021.USD","IE0002270589.USD","LU0225284248.USD","LU1169590202.USD","SG9999001176.USD","IE000M9KFDE8.USD","LU1057294990.SGD","ADC","LU0122379950.USD","LU0225771236.USD","BK4599","BK4568","IE00BLSP4452.SGD","BK4231","BK4588","LU1066051498.USD","BK4534","LU1883839398.USD","BK4592","SG9999003800.SGD","BK4007","LU0306807586.USD","IE00B19Z3581.USD","SG9999002224.SGD","BK4080","BK4023","LU0456855351.SGD","LU0321505439.SGD","LU1066053197.SGD","PD","BK4533","LU1023059063.AUD","SG9999002232.USD","SG9999011175.SGD","IE00B19Z3B42.SGD","SG9999013999.USD","LU0321505868.SGD","IE00BBT3K403.USD","LU0868494617.USD","SG9999001176.SGD","LU0306806265.USD","SGXZ57979304.SGD","LU1169589451.USD","LU1894683348.USD","BK4585","LU0170899867.USD","PFE","LU0058720904.USD","LU1894683264.USD","BK4550"],"gpt_icon":1},{"id":"2534457851","title":"從PD-1跟隨到多款ADC領先，樂普生物-B（02157）迎價值重估？","url":"https://stock-news.laohu8.com/highlight/detail?id=2534457851","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534457851?lang=zh_tw&edition=fundamental","pubTime":"2025-05-09 12:15","pubTimestamp":1746764144,"startTime":"0","endTime":"0","summary":"作为肿瘤治疗领域的新秀，乐普生物-B以PD-1为资本市场所熟知，也因上市初期仅PD-1进展最快，因此自上市以来，乐普生物股价表现并不如意。据wind显示，乐普生物当前股价较2022年上市初期仍处于腰斩状态。得益于PD-1的商业化，2024年乐普生物实现营业收入3.68 亿元人民币，同比增长63.21%。目前乐普生物的在研管线中核心药物为MRG003。乐普生物的免疫疗法中，普特利单抗已上市，加上公司有多款在研的ADC药物，因此联合疗法也成了乐普生物积极布局的方向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1291214.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ADC","LU1169589451.USD","BK4023","LU1169590202.USD","PD","BK1161","BK4231","02157","BK4080"],"gpt_icon":0},{"id":"2533893549","title":"林園持續增配！這個行業利好消息不斷","url":"https://stock-news.laohu8.com/highlight/detail?id=2533893549","media":"证券市场周刊","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533893549?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 18:54","pubTimestamp":1746615240,"startTime":"0","endTime":"0","summary":"近期，中国创新药行业利好消息不断，行业景气度提升明显。每个板块的上涨节奏不同，创新药就是不会持续加速，但其慢牛的上行趋势恰好也是更为稳健且长远的。4月28日，和誉医药和信达生物在AACR年会上展示多项最新临床前数据的信息和时间表。SGC001项目临床试验申请已先后获得FDA及国家药监局的临床批准，并于近日获得FDA授予的快速通道认证。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2025-05-07/doc-inevttzu9533164.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06978","BK4080","ADC","BK4231","BK1574","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ADC\",params:#limit:5,,,undefined,":[{"date":"2025-06-30","symbol":"ADC","amount":0.256,"announcedDate":"2025-06-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-30","defaultRemindTime":1751290200000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-15","payableDate":"2025-06-30","currency":"USD","dateTimestamp":1751256000000,"payDate":"2025-07-15"},{"date":"2025-05-30","symbol":"ADC","amount":0.256,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-30","defaultRemindTime":1748611800000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-13","payableDate":"2025-05-30","currency":"USD","dateTimestamp":1748577600000,"payDate":"2025-06-13"},{"date":"2025-04-30","symbol":"ADC","amount":0.256,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-30","defaultRemindTime":1746019800000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-14","payableDate":"2025-04-30","currency":"USD","dateTimestamp":1745985600000,"payDate":"2025-05-14"},{"market":"US","date":"2025-04-22","symbol":"ADC","fiscalQuarterEnding":"2025/03","expectedEps":1.05,"name":null,"time":"盤後","type":"earning","dateTimestamp":1745294400000,"reportTimeType":"post","actualEps":1.06},{"date":"2025-03-31","symbol":"ADC","amount":0.253,"announcedDate":"2025-03-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-31","defaultRemindTime":1743427800000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-14","payableDate":"2025-03-31","currency":"USD","dateTimestamp":1743393600000,"payDate":"2025-04-14"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ADC\",market:\"US\",,,undefined,":[{"executeDate":"2015-06-26","recordDate":"2015-06-30","paymentDate":"2015-07-14","value":0.465,"currency":"USD"},{"executeDate":"2015-09-28","recordDate":"2015-09-30","paymentDate":"2015-10-13","value":0.465,"currency":"USD"},{"executeDate":"2015-12-18","recordDate":"2015-12-22","paymentDate":"2016-01-05","value":0.465,"currency":"USD"},{"executeDate":"2016-03-29","recordDate":"2016-03-31","paymentDate":"2016-04-15","value":0.465,"currency":"USD"},{"executeDate":"2016-06-28","recordDate":"2016-06-30","paymentDate":"2016-07-15","value":0.48,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ADC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.4286,"hold":0.2857,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4286,"analysts":21,"updateTime":1746676800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ADC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ADC","date":"2025-06-17","current":42.307895,"percent":0.616762,"low":31.539495,"twenty":37.571542,"median":40.666871,"eighty":44.65655,"high":53.261716,"avg":41.111835,"sd":4.469339,"marketCap":8094938718},"quantilePoints":[{"date":"2020-06-19","current":43.938263,"twenty":30.399208,"median":35.674606,"eighty":42.926676,"marketCap":3645250098},{"date":"2020-06-26","current":40.969109,"twenty":30.470777,"median":35.744304,"eighty":42.989446,"marketCap":3398920216},{"date":"2020-07-02","current":43.619209,"twenty":30.497525,"median":35.833506,"eighty":43.024146,"marketCap":3618780439},{"date":"2020-07-10","current":41.587683,"twenty":30.543737,"median":35.93098,"eighty":43.037844,"marketCap":3450238941},{"date":"2020-07-17","current":42.77274,"twenty":30.603622,"median":36.099734,"eighty":43.037844,"marketCap":3548554815},{"date":"2020-07-24","current":37.537078,"twenty":30.71291,"median":36.149452,"eighty":43.037844,"marketCap":3365424257},{"date":"2020-07-31","current":40.350852,"twenty":30.745133,"median":36.199495,"eighty":43.037844,"marketCap":3617696027},{"date":"2020-08-07","current":41.351038,"twenty":30.776927,"median":36.250246,"eighty":43.037844,"marketCap":3707368648},{"date":"2020-08-14","current":40.224323,"twenty":30.922362,"median":36.348523,"eighty":43.037844,"marketCap":3606351900},{"date":"2020-08-21","current":40.308676,"twenty":31.08368,"median":36.544296,"eighty":43.037844,"marketCap":3613914651},{"date":"2020-08-28","current":40.628012,"twenty":31.203975,"median":36.640352,"eighty":43.037844,"marketCap":3642545066},{"date":"2020-09-04","current":40.013441,"twenty":31.296906,"median":36.781594,"eighty":43.037844,"marketCap":3587445022},{"date":"2020-09-11","current":40.079718,"twenty":31.383772,"median":36.974643,"eighty":43.037844,"marketCap":3593387184},{"date":"2020-09-18","current":38.59149,"twenty":31.509762,"median":37.052903,"eighty":43.037844,"marketCap":3459958646},{"date":"2020-09-25","current":37.645532,"twenty":31.534039,"median":37.273263,"eighty":43.037844,"marketCap":3375147794},{"date":"2020-10-02","current":39.29644,"twenty":31.704694,"median":37.362034,"eighty":43.037844,"marketCap":3523161638},{"date":"2020-10-09","current":40.368928,"twenty":31.803276,"median":37.497873,"eighty":43.037844,"marketCap":3619316617},{"date":"2020-10-16","current":39.386818,"twenty":31.867808,"median":37.57347,"eighty":43.037844,"marketCap":3531264585},{"date":"2020-10-23","current":40.224079,"twenty":31.975443,"median":37.612137,"eighty":43.037844,"marketCap":3633239960},{"date":"2020-10-30","current":38.164301,"twenty":31.975443,"median":37.733323,"eighty":43.037844,"marketCap":3447190528},{"date":"2020-11-06","current":38.797606,"twenty":31.975443,"median":37.935059,"eighty":43.037844,"marketCap":3504393786},{"date":"2020-11-13","current":41.26934,"twenty":31.975443,"median":38.046028,"eighty":43.037844,"marketCap":3727653105},{"date":"2020-11-20","current":40.039622,"twenty":31.975443,"median":38.167733,"eighty":43.037844,"marketCap":3616578817},{"date":"2020-11-27","current":40.506914,"twenty":31.975443,"median":38.310136,"eighty":43.037844,"marketCap":3658787046},{"date":"2020-12-04","current":40.580698,"twenty":31.975443,"median":38.471704,"eighty":43.037844,"marketCap":3665451504},{"date":"2020-12-11","current":40.230228,"twenty":31.975443,"median":38.545534,"eighty":43.037844,"marketCap":3633795331},{"date":"2020-12-18","current":39.344831,"twenty":31.975443,"median":38.676992,"eighty":43.037844,"marketCap":3553821844},{"date":"2020-12-24","current":39.762935,"twenty":31.975443,"median":38.782235,"eighty":43.037844,"marketCap":3591587102},{"date":"2020-12-31","current":40.937316,"twenty":31.975443,"median":38.892751,"eighty":43.037844,"marketCap":3697663047},{"date":"2021-01-08","current":45.450661,"twenty":31.975443,"median":39.008592,"eighty":43.047885,"marketCap":4105330986},{"date":"2021-01-15","current":44.653159,"twenty":31.975443,"median":39.245492,"eighty":43.22631,"marketCap":4033296550},{"date":"2021-01-22","current":45.359718,"twenty":31.975443,"median":39.341757,"eighty":43.313411,"marketCap":4097116533},{"date":"2021-01-29","current":44.212433,"twenty":31.975443,"median":39.41667,"eighty":43.4163,"marketCap":3993488046},{"date":"2021-02-05","current":46.262155,"twenty":31.975443,"median":39.41667,"eighty":43.554978,"marketCap":4178629185},{"date":"2021-02-12","current":45.520618,"twenty":31.975443,"median":39.41667,"eighty":43.618647,"marketCap":4111649797},{"date":"2021-02-19","current":43.859591,"twenty":31.975443,"median":39.41667,"eighty":43.642628,"marketCap":4007933303},{"date":"2021-02-26","current":44.718497,"twenty":31.977009,"median":39.430911,"eighty":43.756513,"marketCap":4086420942},{"date":"2021-03-05","current":44.656157,"twenty":31.975443,"median":39.41667,"eighty":43.796506,"marketCap":4080724259},{"date":"2021-03-12","current":46.594043,"twenty":31.975443,"median":39.41667,"eighty":43.856021,"marketCap":4257810284},{"date":"2021-03-19","current":46.240217,"twenty":31.975443,"median":39.41667,"eighty":43.889974,"marketCap":4225477299},{"date":"2021-03-26","current":46.69811,"twenty":31.977009,"median":39.430911,"eighty":43.995818,"marketCap":4267319985},{"date":"2021-04-01","current":47.239256,"twenty":31.977009,"median":39.430911,"eighty":44.083322,"marketCap":4316770432},{"date":"2021-04-09","current":47.1005,"twenty":31.975443,"median":39.41667,"eighty":44.146464,"marketCap":4304090831},{"date":"2021-04-16","current":47.627771,"twenty":31.975443,"median":39.41667,"eighty":44.201737,"marketCap":4352273317},{"date":"2021-04-23","current":49.334461,"twenty":31.975443,"median":39.41667,"eighty":44.216631,"marketCap":4508232419},{"date":"2021-04-30","current":48.814129,"twenty":31.975443,"median":39.41667,"eighty":44.274005,"marketCap":4460683913},{"date":"2021-05-07","current":44.881383,"twenty":31.975443,"median":39.41667,"eighty":44.314742,"marketCap":4499986938},{"date":"2021-05-14","current":44.377456,"twenty":31.975443,"median":39.41667,"eighty":44.249425,"marketCap":4449461218},{"date":"2021-05-21","current":44.026621,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4414285084},{"date":"2021-05-28","current":44.830352,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4494870410},{"date":"2021-06-04","current":45.665977,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4578653566},{"date":"2021-06-11","current":45.646841,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4576734868},{"date":"2021-06-18","current":47.246871,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4737160278},{"date":"2021-06-25","current":48.748389,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4887708512},{"date":"2021-07-02","current":48.211648,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4833892628},{"date":"2021-07-09","current":49.210395,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4934031046},{"date":"2021-07-16","current":49.93058,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":5006239701},{"date":"2021-07-23","current":50.956505,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":5109102975},{"date":"2021-07-30","current":53.056971,"twenty":31.977009,"median":39.430911,"eighty":44.230599,"marketCap":5165308396},{"date":"2021-08-06","current":52.598062,"twenty":31.977009,"median":39.430911,"eighty":44.296692,"marketCap":5120631744},{"date":"2021-08-13","current":52.520401,"twenty":31.977009,"median":39.430911,"eighty":44.412506,"marketCap":5113071079},{"date":"2021-08-20","current":52.718085,"twenty":31.977009,"median":39.430911,"eighty":44.625208,"marketCap":5132316407},{"date":"2021-08-27","current":52.209754,"twenty":31.977009,"median":39.430911,"eighty":44.658936,"marketCap":5082828422},{"date":"2021-09-03","current":52.675724,"twenty":31.977009,"median":39.430911,"eighty":44.712504,"marketCap":5128192408},{"date":"2021-09-10","current":49.555141,"twenty":31.977009,"median":39.430911,"eighty":44.74795,"marketCap":4824391169},{"date":"2021-09-17","current":50.119952,"twenty":31.977009,"median":39.430911,"eighty":44.835833,"marketCap":4879377818},{"date":"2021-09-24","current":47.775985,"twenty":31.977009,"median":39.430911,"eighty":44.888065,"marketCap":4651183223},{"date":"2021-10-01","current":47.352376,"twenty":31.977009,"median":39.430911,"eighty":44.941549,"marketCap":4609943235},{"date":"2021-10-08","current":47.670083,"twenty":31.977009,"median":39.430911,"eighty":44.9864,"marketCap":4640873226},{"date":"2021-10-15","current":49.02563,"twenty":31.977009,"median":39.430911,"eighty":45.094688,"marketCap":4772841185},{"date":"2021-10-22","current":49.5269,"twenty":31.977009,"median":39.430911,"eighty":45.190701,"marketCap":4821641836},{"date":"2021-10-29","current":50.169373,"twenty":32.013133,"median":39.571166,"eighty":45.28245,"marketCap":4884189150},{"date":"2021-11-05","current":43.773853,"twenty":32.013133,"median":39.651928,"eighty":45.28245,"marketCap":4934976633},{"date":"2021-11-12","current":43.137928,"twenty":32.029424,"median":39.72736,"eighty":45.28245,"marketCap":4863283742},{"date":"2021-11-19","current":43.008274,"twenty":32.198132,"median":39.802558,"eighty":45.28245,"marketCap":4848666745},{"date":"2021-11-26","current":42.662528,"twenty":32.27459,"median":39.842867,"eighty":45.28245,"marketCap":4809688086},{"date":"2021-12-03","current":42.508177,"twenty":32.348817,"median":39.911012,"eighty":45.28245,"marketCap":4792286899},{"date":"2021-12-10","current":42.891493,"twenty":32.447032,"median":39.953188,"eighty":45.28245,"marketCap":4835501148},{"date":"2021-12-17","current":45.380751,"twenty":32.521786,"median":39.996581,"eighty":45.380751,"marketCap":5116135105},{"date":"2021-12-23","current":46.352906,"twenty":32.588031,"median":40.079057,"eighty":45.406143,"marketCap":5225733953},{"date":"2021-12-31","current":48.175698,"twenty":32.64443,"median":40.10618,"eighty":45.47788,"marketCap":5431231792},{"date":"2022-01-07","current":46.703962,"twenty":32.651599,"median":40.164071,"eighty":45.565296,"marketCap":5265311314},{"date":"2022-01-14","current":46.015352,"twenty":32.70478,"median":40.208708,"eighty":45.667046,"marketCap":5187678797},{"date":"2022-01-21","current":43.267663,"twenty":32.731462,"median":40.224323,"eighty":45.667046,"marketCap":4877909831},{"date":"2022-01-28","current":43.821252,"twenty":32.743358,"median":40.249944,"eighty":45.667046,"marketCap":4940320287},{"date":"2022-02-04","current":42.666817,"twenty":32.769192,"median":40.314701,"eighty":45.667046,"marketCap":4810171655},{"date":"2022-02-11","current":42.565551,"twenty":32.769192,"median":40.347561,"eighty":45.667046,"marketCap":4798755108},{"date":"2022-02-18","current":42.943612,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4841376882},{"date":"2022-02-25","current":37.784604,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4620036905},{"date":"2022-03-04","current":38.267307,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4679058463},{"date":"2022-03-11","current":37.29027,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4559593141},{"date":"2022-03-18","current":37.24956,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4554615419},{"date":"2022-03-25","current":38.110019,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4659826391},{"date":"2022-04-01","current":39.298046,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4805089927},{"date":"2022-04-08","current":39.763938,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4862056020},{"date":"2022-04-14","current":40.742313,"twenty":32.769192,"median":40.404479,"eighty":45.667046,"marketCap":4981684815},{"date":"2022-04-22","current":42.01187,"twenty":32.769192,"median":40.455317,"eighty":45.667046,"marketCap":5136917418},{"date":"2022-04-29","current":39.554287,"twenty":32.79826,"median":40.479695,"eighty":45.667046,"marketCap":4836421278},{"date":"2022-05-06","current":39.499614,"twenty":32.904642,"median":40.479695,"eighty":45.667046,"marketCap":5066773466},{"date":"2022-05-13","current":39.967203,"twenty":32.996397,"median":40.479695,"eighty":45.667046,"marketCap":5126753027},{"date":"2022-05-20","current":39.90291,"twenty":33.05702,"median":40.479695,"eighty":45.667046,"marketCap":5118505838},{"date":"2022-05-27","current":40.353768,"twenty":33.088236,"median":40.495181,"eighty":45.667046,"marketCap":5176339242},{"date":"2022-06-03","current":40.599257,"twenty":33.156377,"median":40.53176,"eighty":45.667046,"marketCap":5207829139},{"date":"2022-06-10","current":41.119461,"twenty":33.227354,"median":40.613635,"eighty":45.667046,"marketCap":5274557730},{"date":"2022-06-17","current":40.213488,"twenty":33.270165,"median":40.613635,"eighty":45.667046,"marketCap":5158345016},{"date":"2022-06-24","current":43.32302,"twenty":33.260026,"median":40.659236,"eighty":45.668114,"marketCap":5557217043},{"date":"2022-07-01","current":42.978166,"twenty":33.330747,"median":40.684242,"eighty":45.668114,"marketCap":5512981235},{"date":"2022-07-08","current":42.872956,"twenty":33.466784,"median":40.715658,"eighty":45.668114,"marketCap":5499485565},{"date":"2022-07-15","current":43.708789,"twenty":33.59929,"median":40.742313,"eighty":45.668114,"marketCap":5606701167},{"date":"2022-07-22","current":44.556311,"twenty":33.59929,"median":40.778643,"eighty":45.668114,"marketCap":5715416287},{"date":"2022-07-29","current":46.520226,"twenty":33.675236,"median":40.820493,"eighty":45.678143,"marketCap":5967335462},{"date":"2022-08-05","current":43.100932,"twenty":33.675236,"median":40.862996,"eighty":45.68777,"marketCap":6116022220},{"date":"2022-08-12","current":44.318758,"twenty":33.675236,"median":40.912721,"eighty":45.68777,"marketCap":6288831702},{"date":"2022-08-19","current":44.509569,"twenty":33.675236,"median":40.969109,"eighty":45.68777,"marketCap":6315907842},{"date":"2022-08-26","current":43.241234,"twenty":33.675236,"median":41.010201,"eighty":45.68777,"marketCap":6135931147},{"date":"2022-09-02","current":41.585665,"twenty":33.675236,"median":41.060268,"eighty":45.68777,"marketCap":5901005814},{"date":"2022-09-09","current":41.956063,"twenty":33.675236,"median":41.092655,"eighty":45.68777,"marketCap":5953565380},{"date":"2022-09-16","current":40.805583,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5790312183},{"date":"2022-09-23","current":39.935707,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5666876838},{"date":"2022-09-30","current":37.927001,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5381841428},{"date":"2022-10-07","current":36.428553,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5169211706},{"date":"2022-10-14","current":35.631626,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5056127734},{"date":"2022-10-21","current":36.636203,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5198677248},{"date":"2022-10-28","current":38.359137,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5443161610},{"date":"2022-11-04","current":41.724424,"twenty":33.675236,"median":41.119461,"eighty":45.68777,"marketCap":6035896875},{"date":"2022-11-11","current":42.347632,"twenty":33.675236,"median":41.160749,"eighty":45.68777,"marketCap":6126050848},{"date":"2022-11-18","current":42.756995,"twenty":33.675236,"median":41.197005,"eighty":45.68777,"marketCap":6185269635},{"date":"2022-11-25","current":43.056379,"twenty":33.675236,"median":41.218321,"eighty":45.68777,"marketCap":6228578896},{"date":"2022-12-02","current":43.196907,"twenty":33.675236,"median":41.257018,"eighty":45.68777,"marketCap":6248907733},{"date":"2022-12-09","current":43.795676,"twenty":33.675236,"median":41.35326,"eighty":45.68777,"marketCap":6335526256},{"date":"2022-12-16","current":43.172467,"twenty":33.675236,"median":41.423201,"eighty":45.68777,"marketCap":6245372283},{"date":"2022-12-23","current":43.685698,"twenty":33.675236,"median":41.463369,"eighty":45.68777,"marketCap":6319616732},{"date":"2022-12-30","current":43.337434,"twenty":33.675236,"median":41.483593,"eighty":45.68777,"marketCap":6269236570},{"date":"2023-01-06","current":43.245786,"twenty":34.167053,"median":41.539601,"eighty":45.68777,"marketCap":6255978633},{"date":"2023-01-13","current":45.714181,"twenty":34.992765,"median":41.587683,"eighty":45.704396,"marketCap":6613059075},{"date":"2023-01-20","current":45.402576,"twenty":35.880519,"median":41.605991,"eighty":45.714503,"marketCap":6567982088},{"date":"2023-01-27","current":45.378137,"twenty":36.169649,"median":41.646285,"eighty":45.714503,"marketCap":6564446638},{"date":"2023-02-03","current":45.255939,"twenty":36.592515,"median":41.674422,"eighty":45.714503,"marketCap":6546769389},{"date":"2023-02-10","current":44.406665,"twenty":36.713651,"median":41.711398,"eighty":45.714503,"marketCap":6423912504},{"date":"2023-02-17","current":44.157808,"twenty":36.89773,"median":41.739833,"eighty":45.714503,"marketCap":6731283715},{"date":"2023-02-24","current":42.410386,"twenty":36.963658,"median":41.754028,"eighty":45.714503,"marketCap":6464912060},{"date":"2023-03-03","current":41.690165,"twenty":37.214665,"median":41.783816,"eighty":45.714503,"marketCap":6355123742},{"date":"2023-03-10","current":39.423241,"twenty":37.286636,"median":41.783816,"eighty":45.714503,"marketCap":6009560514},{"date":"2023-03-17","current":40.355986,"twenty":37.342014,"median":41.783816,"eighty":45.714503,"marketCap":6151745384},{"date":"2023-03-24","current":39.606247,"twenty":37.466803,"median":41.783816,"eighty":45.714503,"marketCap":6037457546},{"date":"2023-03-31","current":40.621801,"twenty":37.536428,"median":41.78137,"eighty":45.714342,"marketCap":6192265465},{"date":"2023-04-06","current":39.692254,"twenty":37.577737,"median":41.783816,"eighty":45.714503,"marketCap":6050568092},{"date":"2023-04-14","current":39.289647,"twenty":37.687654,"median":41.784219,"eighty":45.714663,"marketCap":5989195981},{"date":"2023-04-21","current":39.792905,"twenty":37.872566,"median":41.784621,"eighty":45.714824,"marketCap":6065911119},{"date":"2023-04-28","current":40.118543,"twenty":37.943837,"median":41.797292,"eighty":45.714985,"marketCap":6115550327},{"date":"2023-05-05","current":39.964605,"twenty":38.110019,"median":41.797292,"eighty":45.714985,"marketCap":6092084520},{"date":"2023-05-12","current":39.104119,"twenty":38.249787,"median":41.797292,"eighty":45.714985,"marketCap":6176026400},{"date":"2023-05-19","current":38.898029,"twenty":38.342909,"median":41.797292,"eighty":45.714985,"marketCap":6143476946},{"date":"2023-05-26","current":37.796919,"twenty":38.456408,"median":41.797292,"eighty":45.714985,"marketCap":5969569863},{"date":"2023-06-02","current":37.832249,"twenty":38.456408,"median":41.797292,"eighty":45.714985,"marketCap":5975149770},{"date":"2023-06-09","current":38.668386,"twenty":38.476762,"median":41.797292,"eighty":45.714985,"marketCap":6107207554},{"date":"2023-06-16","current":38.786152,"twenty":38.533217,"median":41.797292,"eighty":45.714985,"marketCap":6125807242},{"date":"2023-06-23","current":38.509402,"twenty":38.553397,"median":41.809962,"eighty":45.718688,"marketCap":6082097976},{"date":"2023-06-30","current":38.55062,"twenty":38.5799,"median":41.81327,"eighty":45.72239,"marketCap":6088607866},{"date":"2023-07-07","current":38.662498,"twenty":38.628346,"median":41.81327,"eighty":45.72239,"marketCap":6106277570},{"date":"2023-07-14","current":38.603615,"twenty":38.628346,"median":41.81327,"eighty":45.72239,"marketCap":6096977726},{"date":"2023-07-21","current":39.357316,"twenty":38.659115,"median":41.81327,"eighty":45.72239,"marketCap":6216015729},{"date":"2023-07-28","current":39.404422,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":6223455604},{"date":"2023-08-04","current":38.053978,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":6196443469},{"date":"2023-08-11","current":37.511193,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":6108060089},{"date":"2023-08-18","current":36.166029,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5889023018},{"date":"2023-08-25","current":36.531819,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5948585730},{"date":"2023-09-01","current":36.472821,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5938978841},{"date":"2023-09-08","current":35.75304,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5821774794},{"date":"2023-09-15","current":35.446248,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5771818971},{"date":"2023-09-22","current":33.711695,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5489376431},{"date":"2023-09-29","current":32.567126,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5303002783},{"date":"2023-10-06","current":32.649724,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5316452427},{"date":"2023-10-13","current":31.806046,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5179073913},{"date":"2023-10-20","current":32.41963,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5278985560},{"date":"2023-10-27","current":33.181375,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5472604212},{"date":"2023-11-03","current":35.377246,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5834769220},{"date":"2023-11-10","current":34.598655,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5706356142},{"date":"2023-11-17","current":35.425908,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5842795038},{"date":"2023-11-24","current":35.170433,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5800659496},{"date":"2023-12-01","current":36.015934,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5940108073},{"date":"2023-12-08","current":36.873602,"twenty":38.730653,"median":41.843819,"eighty":45.729795,"marketCap":6081563104},{"date":"2023-12-15","current":37.7556,"twenty":38.730653,"median":41.843819,"eighty":45.729795,"marketCap":6227031044},{"date":"2023-12-22","current":37.968496,"twenty":38.730653,"median":41.843819,"eighty":45.729795,"marketCap":6262143995},{"date":"2023-12-29","current":38.607184,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":6367482847},{"date":"2024-01-05","current":38.296964,"twenty":38.756995,"median":41.871582,"eighty":45.73451,"marketCap":6316318262},{"date":"2024-01-12","current":38.090151,"twenty":38.758791,"median":41.871582,"eighty":45.73451,"marketCap":6282208538},{"date":"2024-01-19","current":36.989174,"twenty":38.764196,"median":41.872103,"eighty":45.735522,"marketCap":6100624420},{"date":"2024-01-26","current":36.295741,"twenty":38.758791,"median":41.871582,"eighty":45.73451,"marketCap":5986256523},{"date":"2024-02-02","current":37.232484,"twenty":38.697827,"median":41.871582,"eighty":45.73451,"marketCap":6140753507},{"date":"2024-02-09","current":35.261674,"twenty":38.661168,"median":41.871582,"eighty":45.73451,"marketCap":5815707904},{"date":"2024-02-16","current":33.847315,"twenty":38.629468,"median":41.871582,"eighty":45.73451,"marketCap":5752655855},{"date":"2024-02-23","current":33.670228,"twenty":38.597685,"median":41.871582,"eighty":45.73451,"marketCap":5722558249},{"date":"2024-03-01","current":32.436519,"twenty":38.556509,"median":41.871061,"eighty":45.733498,"marketCap":5512878257},{"date":"2024-03-08","current":33.758772,"twenty":38.535146,"median":41.871061,"eighty":45.733498,"marketCap":5737607052},{"date":"2024-03-15","current":32.6018,"twenty":38.489062,"median":41.871061,"eighty":45.733498,"marketCap":5540969356},{"date":"2024-03-22","current":33.262927,"twenty":38.456408,"median":41.871061,"eighty":45.733498,"marketCap":5653333754},{"date":"2024-03-28","current":33.457723,"twenty":38.385748,"median":41.784621,"eighty":45.733498,"marketCap":5686441121},{"date":"2024-04-05","current":33.192092,"twenty":38.338315,"median":41.766476,"eighty":45.73451,"marketCap":5641294711},{"date":"2024-04-12","current":33.499043,"twenty":38.271415,"median":41.746116,"eighty":45.73451,"marketCap":5693463896},{"date":"2024-04-19","current":32.99201,"twenty":38.226469,"median":41.73308,"eighty":45.73451,"marketCap":5607289064},{"date":"2024-04-26","current":33.647761,"twenty":38.150217,"median":41.720309,"eighty":45.733498,"marketCap":5827926731},{"date":"2024-05-03","current":33.618779,"twenty":38.090151,"median":41.711398,"eighty":45.733498,"marketCap":5822906984},{"date":"2024-05-10","current":34.482434,"twenty":38.029323,"median":41.69585,"eighty":45.733498,"marketCap":5972495456},{"date":"2024-05-17","current":34.986715,"twenty":37.950247,"median":41.66791,"eighty":45.733498,"marketCap":6059839061},{"date":"2024-05-24","current":34.198413,"twenty":37.871294,"median":41.619337,"eighty":45.733498,"marketCap":5923301932},{"date":"2024-05-31","current":34.928752,"twenty":37.820473,"median":41.602226,"eighty":45.733498,"marketCap":6049799566},{"date":"2024-06-07","current":35.908334,"twenty":37.7418,"median":41.585665,"eighty":45.733498,"marketCap":6219467028},{"date":"2024-06-14","current":35.311311,"twenty":37.642264,"median":41.478607,"eighty":45.73451,"marketCap":6116060232},{"date":"2024-06-21","current":35.485201,"twenty":37.563829,"median":41.447441,"eighty":45.735522,"marketCap":6146178716},{"date":"2024-06-28","current":35.734443,"twenty":37.537078,"median":41.447441,"eighty":45.738558,"marketCap":6189348544},{"date":"2024-07-05","current":35.879352,"twenty":37.482188,"median":41.447441,"eighty":45.738558,"marketCap":6214447281},{"date":"2024-07-12","current":36.957471,"twenty":37.418215,"median":41.439295,"eighty":45.738558,"marketCap":6401181884},{"date":"2024-07-15","current":37.189325,"twenty":37.412399,"median":41.439295,"eighty":45.738558,"marketCap":6441339863},{"date":"2024-08-02","current":37.993919,"twenty":37.339153,"median":41.40142,"eighty":45.707657,"marketCap":7107142493},{"date":"2024-08-09","current":38.417922,"twenty":37.339153,"median":41.351038,"eighty":45.669183,"marketCap":7186456557},{"date":"2024-08-16","current":38.455492,"twenty":37.339153,"median":41.248609,"eighty":45.587895,"marketCap":7193484385},{"date":"2024-08-23","current":38.879496,"twenty":37.339153,"median":41.197005,"eighty":45.51208,"marketCap":7272798449},{"date":"2024-08-30","current":39.104915,"twenty":37.339153,"median":41.152223,"eighty":45.432939,"marketCap":7314965420},{"date":"2024-09-06","current":40.19981,"twenty":37.339153,"median":41.109476,"eighty":45.406991,"marketCap":7519776420},{"date":"2024-09-13","current":40.725789,"twenty":37.339153,"median":41.060268,"eighty":45.379705,"marketCap":7618166018},{"date":"2024-09-20","current":39.786541,"twenty":37.339153,"median":41.020981,"eighty":45.296882,"marketCap":7442470307},{"date":"2024-09-27","current":39.931453,"twenty":37.339153,"median":40.992653,"eighty":45.271719,"marketCap":7469577645},{"date":"2024-10-04","current":40.355457,"twenty":37.339153,"median":40.937316,"eighty":45.211095,"marketCap":7548891709},{"date":"2024-10-11","current":39.3196,"twenty":37.339153,"median":40.894276,"eighty":45.159517,"marketCap":7355124439},{"date":"2024-10-18","current":40.731156,"twenty":37.339153,"median":40.838938,"eighty":45.089028,"marketCap":7619169993},{"date":"2024-10-25","current":42.532506,"twenty":37.339153,"median":40.820493,"eighty":45.046981,"marketCap":8077475775},{"date":"2024-10-31","current":40.816625,"twenty":37.339153,"median":40.816625,"eighty":44.988744,"marketCap":7751607762},{"date":"2024-11-08","current":40.076878,"twenty":37.338438,"median":40.773001,"eighty":44.942004,"marketCap":7611120201},{"date":"2024-11-15","current":41.115788,"twenty":37.338438,"median":40.773001,"eighty":44.942004,"marketCap":7808422584},{"date":"2024-11-22","current":41.948003,"twenty":37.338438,"median":40.773001,"eighty":44.914929,"marketCap":7966471090},{"date":"2024-11-29","current":41.773945,"twenty":37.338438,"median":40.773001,"eighty":44.914324,"marketCap":7933415193},{"date":"2024-12-06","current":40.849261,"twenty":37.338438,"median":40.770318,"eighty":44.892115,"marketCap":7757805742},{"date":"2024-12-13","current":40.055121,"twenty":37.338438,"median":40.736734,"eighty":44.892115,"marketCap":7606988214},{"date":"2024-12-20","current":37.770608,"twenty":37.338438,"median":40.680888,"eighty":44.892115,"marketCap":7173129570},{"date":"2024-12-27","current":38.515795,"twenty":37.338438,"median":40.640959,"eighty":44.892115,"marketCap":7314650128},{"date":"2025-01-03","current":37.933788,"twenty":37.338438,"median":40.614232,"eighty":44.892115,"marketCap":7204119473},{"date":"2025-01-10","current":37.906591,"twenty":37.337724,"median":40.580698,"eighty":44.89414,"marketCap":7198954490},{"date":"2025-01-17","current":39.244663,"twenty":37.333873,"median":40.538993,"eighty":44.89414,"marketCap":7453071695},{"date":"2025-01-24","current":38.87479,"twenty":37.333873,"median":40.501145,"eighty":44.89414,"marketCap":7382827915},{"date":"2025-01-31","current":39.761398,"twenty":37.333873,"median":40.465332,"eighty":44.84311,"marketCap":7551206388},{"date":"2025-02-07","current":39.74508,"twenty":37.333873,"median":40.424995,"eighty":44.718497,"marketCap":7548107398},{"date":"2025-02-14","current":40.634976,"twenty":37.333873,"median":40.403761,"eighty":44.67404,"marketCap":7688015540},{"date":"2025-02-21","current":40.363435,"twenty":37.333873,"median":40.374953,"eighty":44.653159,"marketCap":7636640801},{"date":"2025-02-28","current":41.687197,"twenty":37.333873,"median":40.374953,"eighty":44.559412,"marketCap":7887092651},{"date":"2025-03-07","current":42.394335,"twenty":37.33306,"median":40.37194,"eighty":44.562299,"marketCap":8020881032},{"date":"2025-03-14","current":42.767704,"twenty":37.33306,"median":40.383179,"eighty":44.562299,"marketCap":8091521298},{"date":"2025-03-21","current":43.141073,"twenty":37.417052,"median":40.40791,"eighty":44.562299,"marketCap":8162161563},{"date":"2025-03-28","current":42.993988,"twenty":37.479862,"median":40.452151,"eighty":44.562299,"marketCap":8134333580},{"date":"2025-04-04","current":43.440899,"twenty":37.536428,"median":40.487288,"eighty":44.562299,"marketCap":8218887836},{"date":"2025-04-11","current":41.268572,"twenty":37.537078,"median":40.501145,"eighty":44.559412,"marketCap":7807889929},{"date":"2025-04-17","current":44.145605,"twenty":37.540692,"median":40.519212,"eighty":44.559412,"marketCap":8352216066},{"date":"2025-04-25","current":43.782817,"twenty":37.571542,"median":40.572736,"eighty":44.653759,"marketCap":8377141546},{"date":"2025-05-02","current":45.953462,"twenty":37.571542,"median":40.583839,"eighty":44.677947,"marketCap":8792459672},{"date":"2025-05-09","current":43.031008,"twenty":37.571542,"median":40.598117,"eighty":44.677947,"marketCap":8233294969},{"date":"2025-05-16","current":42.422675,"twenty":37.571542,"median":40.624906,"eighty":44.677947,"marketCap":8116900028},{"date":"2025-05-23","current":42.755537,"twenty":37.571542,"median":40.666871,"eighty":44.677947,"marketCap":8180587826},{"date":"2025-05-30","current":42.698147,"twenty":37.571542,"median":40.666871,"eighty":44.677947,"marketCap":8169607171},{"date":"2025-06-06","current":42.411197,"twenty":37.571542,"median":40.666871,"eighty":44.666838,"marketCap":8114703897},{"date":"2025-06-13","current":42.927706,"twenty":37.571542,"median":40.666871,"eighty":44.666838,"marketCap":8213529790},{"date":"2025-06-17","current":42.307895,"twenty":37.571542,"median":40.666871,"eighty":44.65655,"marketCap":8094938718}],"updateTime":1750242127313}}}